Six people tests coronavirus positive in Maha FDA
A majority of them contracted the virus during field visits
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers
Serum to apply for local trials on Oxford’s vaccine in a week: CEO
SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the…
FabiFlu more affordable than other drugs: Glenmark to DCGI
The company also sends its justifications and clarifications to allegations of false claims about FabiFlu’s use for COVID-19…
Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins
Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of…
Over 158 applications for generic products pending with US FDA for approval: Lupin
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business…
OPTIMA launches GreenLution, a new sustainable capsule system
Working together with the companies Wipf and säntis packaging, Optima has developed a completely recyclable capsule system. It…
DCGI nod for Jubilant’s generic remdesivir under brand name JUBI-R
The company will distribute the drug in the Indian market through its distribution network and will be available by the first week…
China’s indigenously developed COVID-19 vaccines set to surprise the world: GlobalData
China's Sinopharm and Sinovac (in collaboration with Brazil-based Butantan) have both reported encouraging results in the early…
Draw up immunisation strategy now itself for COVID-19 vaccine: Kiran Mazumdar-Shaw
"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by…